country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-15581

Copy Link Print Information

MMAD

Name: MMAD
Brand: MedChemExpress
SKU: HY-15581
Price: 80.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(別名: Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10)

カスタマーレビュー

Based on 1 Customer Validation

MMAD is a potent tubulin inhibitor, is a toxin payload in antibody agent conjugates (ADCs).

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 98.94%
CAS 番号: 203849-91-6
分子式: C₄₁H₆₆N₆O₆S
分子量:771.06

保管条件:

4°C, stored under nitrogen

* The compound is unstable in solutions, freshly prepared is recommended.

MMAD 構造式

CAS 番号: 203849-91-6

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

One-stop CDMO Service

One-Stop Platform：From Independent R&D to Pilot-Scale Production

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体外実験
- 体内実験
化学情報
溶剤 & 溶解度
- 体外
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

MMAD is a potent tubulin inhibitor, is a toxin payload in antibody agent conjugates (ADCs).

IC₅₀ & Target

Auristatin

ADC Payloads アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
BT-474	GI₅₀	0.12 nM Compound: 2, MMAD	Cytotoxicity against human BT474 cells assessed as cell viability incubated fore 4 days by MTS assay Cytotoxicity against human BT474 cells assessed as cell viability incubated fore 4 days by MTS assay	[PMID: 25431858]
MDA-MB-361	GI₅₀	0.09 nM Compound: 2, MMAD	Cytotoxicity against human MDA-MB-361 cells assessed as cell viability incubated fore 4 days by MTS assay Cytotoxicity against human MDA-MB-361 cells assessed as cell viability incubated fore 4 days by MTS assay	[PMID: 25431858]
NCI-N87	GI₅₀	0.3 nM Compound: 2, MMAD	Cytotoxicity against human NCI-N87 cells assessed as cell viability incubated fore 4 days by MTS assay Cytotoxicity against human NCI-N87 cells assessed as cell viability incubated fore 4 days by MTS assay	[PMID: 25431858]

体外実験

MMAD (Monomethyl Dolastatin 10) is coupled through a stable oxime-ligation process to yield several near-homogenous antibody-drug conjugates (ADCs) with a drug-to-antibody ratio of ~2.0. The resulting conjugates demonstrate good pharmacokinetic properties, potent in vitro cytotoxic activity against HER2+ cancer cells. When compared with ADCs prepared by cysteine alkylation following native interchain disulfide reduction, site-specific unnatural-amino-acid-based ADCs are shown to have increased in vitro cytotoxicity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

The resulting antibody-drug conjugates (ADCs) demonstrate complete tumour regression in rodents. They also have an improved toxicology profile in rats^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

化学情報

CAS 番号 203849-91-6
性状 Solid
分子量 771.06
分子式 C₄₁H₆₆N₆O₆S
Color White to off-white
SMILES

O=C([C@H](C)[C@H]([C@]1([H])CCCN1C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C([C@@H](NC([C@@H](N(C)[H])C(C)C)=O)C(C)C)=O)C)=O)OC)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3
別名

Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

4°C, stored under nitrogen

* The compound is unstable in solutions, freshly prepared is recommended.

溶剤 & 溶解度

体外:

DMSO : ≥ 100 mg/mL (129.69 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.2969 mL

6.4846 mL

12.9692 mL

5 mM

0.2594 mL

1.2969 mL

2.5938 mL

10 mM

0.1297 mL

0.6485 mL

1.2969 mL

Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (274 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Chudasama V, et al. Recent advances in the construction of antibody-drug conjugates. Nat Chem. 2016 Feb;8(2):114-9. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	1.2969 mL	6.4846 mL	12.9692 mL	32.4229 mL
	5 mM	0.2594 mL	1.2969 mL	2.5938 mL	6.4846 mL
	10 mM	0.1297 mL	0.6485 mL	1.2969 mL	3.2423 mL
	15 mM	0.0865 mL	0.4323 mL	0.8646 mL	2.1615 mL
	20 mM	0.0648 mL	0.3242 mL	0.6485 mL	1.6211 mL
	25 mM	0.0519 mL	0.2594 mL	0.5188 mL	1.2969 mL
	30 mM	0.0432 mL	0.2162 mL	0.4323 mL	1.0808 mL
	40 mM	0.0324 mL	0.1621 mL	0.3242 mL	0.8106 mL
	50 mM	0.0259 mL	0.1297 mL	0.2594 mL	0.6485 mL
	60 mM	0.0216 mL	0.1081 mL	0.2162 mL	0.5404 mL
	80 mM	0.0162 mL	0.0811 mL	0.1621 mL	0.4053 mL
	100 mM	0.0130 mL	0.0648 mL	0.1297 mL	0.3242 mL

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
- 体内実験
化学情報
溶剤 & 溶解度
- 体外実験
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

MMAD

Monomethyl auristatin E

MMAF

Paclitaxel

Dolastatin 10

PNU-159682

PF-06380101

Doxorubicin hydrochloride

Eribulin

Monomethyl auristatin E (Standard)

DXd

Mertansine

Monomethyl auristatin E (GMP)

ADC Payloads アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Bioz

MMAD

Monomethyl auristatin E

MMAF

Paclitaxel

Dolastatin 10

PNU-159682

PF-06380101

Doxorubicin hydrochloride

Eribulin

Monomethyl auristatin E (Standard)

DXd

Mertansine

Monomethyl auristatin E (GMP)

ADC Payloads アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

MMAD 関連分類

HY-15581 関連分類

Bioz